Proteomics

Dataset Information

24

Mode of action studies for a novel anti-leishmania compound


ABSTRACT: We describe the development of a novel anti-leishmanial drug-like chemical series based on a pyrazolopyrimidine scaffold. The leading compound is efficacious in a mouse model of visceral leishmaniasis, and has suitable physicochemical, pharmacokinetic and toxicological properties for further development and has been declared a preclinical candidate. Detailed mode of action studies indicate that compounds from this series act principally by inhibiting the parasite protein kinases.

INSTRUMENT(S): LTQ Orbitrap Velos

ORGANISM(S): Leishmania donovani  

TISSUE(S): Tissue Not Applicable To Dataset

DISEASE(S): Visceral Leishmaniasis

SUBMITTER: Michael Urbaniak  

LAB HEAD: Ian H Gilbert

PROVIDER: PXD009711 | Pride | 2018-11-30

REPOSITORIES: Pride

Similar Datasets

2008-06-26 | E-MEXP-1539 | ArrayExpress
2012-05-29 | E-GEOD-37593 | ArrayExpress
2009-10-15 | E-GEOD-18554 | ArrayExpress
2016-02-08 | E-GEOD-71292 | ArrayExpress
2010-05-22 | E-GEOD-18049 | ArrayExpress
2019-06-13 | PXD013488 | Pride
2013-04-18 | E-GEOD-46160 | ArrayExpress
2018-05-09 | PXD005798 | Pride
2017-05-24 | PXD006279 | Pride
2013-04-18 | E-GEOD-46162 | ArrayExpress